FDA Approves First Non-Antipsychotic Drug for Alzheimer’s Agitation
(MedPage Today) -- The FDA expanded the indication for dextromethorphan hydrobromide and bupropion hydrochloride (Auvelity) extended-release tablets to treat agitation ...
(MedPage Today) -- The FDA expanded the indication for dextromethorphan hydrobromide and bupropion hydrochloride (Auvelity) extended-release tablets to treat agitation ...
(MedPage Today) -- The FDA has given the green light to an expanded access program (EAP) for the investigational pancreatic ...
(MedPage Today) -- Treatment with oral semaglutide (Rybelsus) significantly improved motivation measures in patients with major depressive disorder (MDD), according ...
The FDA advised healthcare professionals to discuss Tavneos and alternative treatment options with patients while a final decision on the ...
(MedPage Today) -- The first interim safety results from a multicenter, safety surveillance study of Alzheimer's disease patients treated with ...
(MedPage Today) -- SAN DIEGO -- Two phase I/II studies showed that the investigational RAS(ON) inhibitor daraxonrasib had a manageable ...
(MedPage Today) -- The FDA expanded the approval for teplizumab (Tzield), a biologic that delays the progression of preclinical type ...
(MedPage Today) -- President Donald Trump's acting attorney general on Thursday signed an order reclassifying state-licensed medical marijuana as a ...
(MedPage Today) -- SAN DIEGO -- Investigational zoldonrasib was well tolerated and showed encouraging clinical activity in previously treated KRAS ...
Park Bom dished out some heartfelt praises for her fellow 2NE1 members including Sandara Park. Source: www.philstar.com Medical Disclaimer: This ...
© 2025 PickByDoc. All rights reserved. PickByDoc is a medical news & health awareness platform.